TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
126 hedge funds and large institutions have $559M invested in Tvardi Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-9
Holders Change %
-6.67%
% of All Funds
2.74%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
15
Increased
47
Reduced
28
Closed
21
Calls
$20.9M
Puts
$21.7M
Net Calls
-$759K
Net Calls Change
-$1.48M
Top Buyers
| 1 |
First Manhattan
New York
|
+$20.6M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$20.5M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$20.5M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$12M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.73M |
Top Sellers
| 1 |
RCP
Rho Capital Partners
New York
|
-$6.45M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.96M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.92M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$2.39M |
| 5 |
C
Chescapmanager
Baltimore,
Maryland
|
-$2.17M |
